Needham analysts revised their price target for Equifax shares, reducing it to $300 from the previous $325, while reaffirming their Buy rating on the stock. Currently trading at $248.48, Equifax shows ...

In a report released today, Michael Matson from Needham maintained a Hold rating on Steris (STE – Research Report). The company’s shares opened ...

Seven Reno landmarks, including the Lear Theatre and Black Springs Firehouse, reveal how Black history helped shape Northern Nevada.

Every week throughout the 2024-2025 basketball season, MassLive will release updated boys basketball power rankings for the ...

Needham & Company LLC reissued their buy rating on shares of Braze (NASDAQ:BRZE – Free Report) in a research note issued to ...

A Leesburg, Virginia, man was given a 10-year prison sentence for possession of child sex abuse material and has to register ...

NB Bancorp (NASDAQ:NBBK – Get Free Report) is one of 43 public companies in the “Savings institutions, except federal” ...

The Chinese national entered the United States as a temporary visitor in May 2019 and was required to leave three months ...

Teladoc Health, Inc. (NYSE:TDOC) shares remained under scrutiny as Needham analysts maintained a Hold rating following the company's announcement of a significant acquisition. According to ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.